Clinical Study Guide Could Erode FDA's Least Burdensome Trial Policy - InsideHealthPolicy.com: Proposed FDA guidance for designing high-quality clinical studies in support of medical device premarket approval applications could conflict with previous agency policy for sponsors to conduct the most appropriate trials that might not include a random, double-blind investigation, according to industry sources.
